Analysis of Lung Cancer Tissue With Spatial Frequency Domain Imaging
This study investigates if a new imaging device can detect different types of lung tissue using spatial frequency domain imaging (SFDI). Specifically, this study aims to detect lung nodules within normal lung tissue and determine if lung nodules are cancerous. Patients who have confirmed or suspected lung nodules and who are undergoing resection of those nodules will be recruited for the study. Study participants will undergo standard of care lung nodule resection in the operating room, and the resected specimen will be imaged using the SFDI device immediately after removal from the surgical field. The data captured from the SFDI images will then be compared to the pathology findings to identify optical properties of normal and cancerous lung tissue. Because the intervention is conducted on resected biospecimens, this study yields minimal risk to participants.
Checked against the public recordLast updated Aug 12, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of California, Irvine
- Interventions being studied
- Device: Spatial Frequency Domain Imaging
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Greater than or equal to 18 years old * Suspected or confirmed lung nodule on diagnostic imaging * Undergoing lung resection using an open, endoscopic, or robotic approach * Standard of care orders placed for a pathology assessment of resected lung tissue * Adults undergoing lung resection for a lung mass Exclusion Criteria: * \<18 years old * Pregnant females and incarcerated individuals * No standard of care orders to obtain a pathology assessment * RUSH pathology order for resected lung tissue * Any condition where the principal investigator determines to impact patient safety or quality of care
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of California, Irvine Medical CenterOrange, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 12, 2024. Always confirm current availability with the study team.